Infectious Diseases Vaccines H3N2 viruses mutate during vaccine production but new tech could fix it By Staff Reports 2 months ago In late March 2019, the World Health Organization and a vaccine advisory committee of the
Infectious Diseases Vaccines H3N2 viruses mutate during vaccine production but new tech could fix it By Staff Reports 2 months ago In late March 2019, the World Health Organization and a vaccine advisory committee of the
Immunotherapies Infectious Diseases Vaccines Developing a Vaccine Against Nipah Virus By Staff Reports 2 months ago Nipah virus is a type of RNA virus transmitted from animals to humans. The infection
Vaccines Revealing the Gut’s B-Cell Training Program May Point to New Means of Developing Oral Vaccines By Staff Reports 3 months ago Only a few vaccines – for example, polio and rotavirus – can be given orally.
Environmental Health Personal Health & Wellness Vaccines Measles outbreak: Many states are inadequately vaccinated according to expert By Staff Reports 4 months ago As several reports emerge highlighting measles outbreaks across the country, Virginia Tech infectious disease expert points
Vaccines Repeat Vaccination Is Safe for Most Kids with Mild to Moderate Reactions By Staff Reports 9 months ago Children who experience some type of adverse event following initial immunization have a low rate of
Biotechnology rare diseases Vaccines New vaccine technology shows promise as a tool to combat the opioid crisis By Staff Reports 1 year ago Researchers with the U.S. Military HIV Research Program at the Walter Reed Army Institute of
Biotechnology Gene Therapy Infectious Diseases Vaccines Discovery of key molecules involved in severe malaria By Staff Reports 2 years ago Malaria*1 is one of three major infectious diseases*2 affecting approximately 300 million people every year,
Biotechnology Cell Therapy Clinical Trials Immunotherapies rare diseases Vaccines Trained T-Cells to Target Toxic Viruses in Pediatric Patients New Cellular Therapy Approach for Children with Compromised Immune Systems By Staff Reports 2 years ago Michael Pulsipher, MD, of the Children’s Center for Cancer and Blood Diseases at Children’s Hospital
Biotechnology Cell Therapy Clinical Trials rare diseases Vaccines FDA Announces First Approval of Targeted Therapy Based on Basket Study By Staff Reports 2 years ago Precision medicine clinical trial leads to approval of first treatment for Erdheim-Chester disease The US
Biotechnology Cell Therapy Clinical Trials Gene Therapy Immunotherapies Infectious Diseases Vaccines New molecule shows promise in HIV vaccine design By Staff Reports 2 years ago Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine
Arthritis Vaccines $1.5 Million NIH SBIR Grant to Support Development of Rheumatoid Arthritis Vaccine By Staff Reports 2 years ago Rheumatoid Arthritis is a chronic inflammatory disease that mainly targets the synovial membrane, cartilage and
Immunotherapies Vaccines Experimental HIV vaccine regimen is well-tolerated, elicits immune responses By Staff Reports 2 years ago Results from an early-stage clinical trial called APPROACH show that an investigational HIV vaccine regimen
Vaccines New Process May Lead To Vaccine For Schistosomiasis By Staff Reports 2 years ago Scientists at the Cornell and Ludwig Institute for Cancer Research have developed a way to
Biotechnology cancer Vaccines Immunotherapy with DNA vaccine shows promise for HPV-related head and neck cancer By Staff Reports 2 years ago A novel vaccine therapy can generate immune responses in patients with head and neck squamous
Biotechnology rare diseases Vaccines The “Geneva Signature” Measures the Safety and Efficiency of a Vaccine Against Ebola Virus Disease By Staff Reports 2 years ago An international team based at Geneva University Hospitals (HUG) and at the University of Geneva
Biotechnology Prodrug rare diseases Vaccines Zika Virus Protein Mapped to Speed Search for Cure By Staff Reports 2 years ago A recently-published study shows how Indiana University scientists are speeding the path to new treatments
rare diseases Vaccines New Driver, Target in Advanced Mucosal Melanoma By Staff Reports 2 years ago Not all melanomas are created equal. While most melanomas appear on the skin as the
Clinical Trials Vaccines Penn Team Tracks Rare T Cells in Blood to Better Understand Annual Flu Vaccine By Staff Reports 2 years ago For most vaccines to work the body needs two cell types – B cells and
Biotechnology Immunotherapies Vaccines Cytotoxins Contribute to Virulence of Deadly Epidemic Bacterial Infections By Staff Reports 2 years ago Beginning in the mid-1980s, an epidemic of severe invasive infections caused by Streptococcus pyogenes (S.